NY S04986 | 2017-2018 | General Assembly
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on March 3 2017 - 25% progression, died in committee
Action: 2017-03-03 - REFERRED TO HEALTH
Pending: Senate Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on March 3 2017 - 25% progression, died in committee
Action: 2017-03-03 - REFERRED TO HEALTH
Pending: Senate Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Enacts the pharmaceutical cost transparency act requiring prescription drug manufacturers to file a report disclosing certain financial information pertaining to prescription drugs which have a wholesale acquisition cost of $10,000 or more annually or per course of treatment.
Title
Enacts the pharmaceutical cost transparency act requiring prescription drug manufacturers to file a report disclosing certain financial information pertaining to prescription drugs which have a wholesale acquisition cost of $10,000 or more annually or per course of treatment.
Sponsors
| Sen. Ruben Diaz [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2017-03-03 | Senate | REFERRED TO HEALTH |
